Queen's physician appointed to Cytochroma advisory board
This article was originally published in Scrip
Executive Summary
Cytochroma, a clinical-stage speciality pharmaceutical company specialising in products for vitamin D insufficiency and secondary hyperparathyroidism associated with chronic kidney diseases, has appointed Dr John Cunningham to its scientific advisory board. Dr Cunningham is professor of nephrology at the UCL Medical School and consultant nephrologist at the Royal Free Hospital, both in London. He has also served as an appointed physician to HM the Queen since 2005.